US Broker Ratings

Valneva SE (VALN) Stock Analysis: Exploring a 46.12% Potential Upside in the Biotech Sector

Valneva SE (VALN), a prominent player in the biotechnology sector, is capturing investor attention with its promising innovations in vaccine development. Based in Saint-Herblain, France, Valneva..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Exploring a 15% Upside Potential and Robust Revenue Growth

Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a noteworthy name in the healthcare sector, specifically within the drug manufacturers category. As an established entity with..

uniQure N.V. (QURE) Stock Analysis: Unveiling a 131% Potential Upside in the Biotech Sector

Investors eyeing the dynamic biotechnology sector should not overlook uniQure N.V. (QURE), a Netherlands-based innovator in gene therapy. With its current stock price at $23.93, uniQure..

Butterfly Network, Inc. (BFLY) Investor Outlook: Exploring a 10.20% Upside Potential with Strong Buy Ratings

Butterfly Network, Inc. (NASDAQ: BFLY), a company at the forefront of medical imaging technology, is drawing attention from investors with its innovative ultrasound solutions. Based in..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unveiling a 76% Potential Upside in the Biotech Sector

For investors keen on exploring opportunities within the biotechnology sector, Capricor Therapeutics, Inc. (NASDAQ: CAPR) presents a compelling case. Specializing in the development of transformative cell..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking the 72.58% Potential Upside in Precision Medicine

Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing the attention of investors with its compelling narrative in the biotechnology sector, particularly through its innovative approach to precision..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising 34.95% Upside in the Biotech Arena

Zenas BioPharma, Inc. (NASDAQ: ZBIO) stands out in the healthcare sector as a dynamic player in the biotechnology industry. With a focus on developing transformative immunology-based..

RxSight, Inc. (RXST) Investor Outlook: Navigating the Ups and Downs in the Medical Devices Market

RxSight, Inc. (RXST) operates within the healthcare sector, specifically focusing on medical devices, a domain ripe with innovation and growth potential. Based in Aliso Viejo, California,..

AxoGen, Inc. (AXGN) Stock Analysis: A Promising 8% Potential Upside in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN) is at the forefront of medical innovation, focusing on the development and commercialization of cutting-edge technologies for peripheral nerve regeneration and repair...

Dianthus Therapeutics, Inc. (DNTH): Investor Outlook on a Biotech with 52.99% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology firm based in New York, is making waves in the healthcare sector with its promising pipeline of complement..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unlocking a 77% Potential Upside in Healthcare

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing the attention of investors with its robust potential upside, as the company’s stock currently suggests a remarkable 77% growth..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: A 28% Potential Upside Awaits Investors

Fulgent Genetics, Inc. (NASDAQ: FLGT) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

GH Research PLC (GHRS): Investor Outlook on Potential 139% Upside in Biotech Sector

GH Research PLC (NASDAQ: GHRS), an emerging player in the biotechnology sector, has garnered significant attention from individual investors and analysts alike, thanks to its promising..

Akso Health Group (AHG) Stock Analysis: Navigating a 415% Revenue Surge Amid Uncertain Valuations

Investors eyeing Akso Health Group (NASDAQ: AHG) are met with an intriguing mix of rapid growth and valuation uncertainties. This Qingdao, China-based company operates in the..

Syndax Pharmaceuticals, Inc. (SNDX) Investor Outlook: Promising 87% Upside with Pioneering Cancer Therapies

Syndax Pharmaceuticals, Inc. (SNDX), a key player in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment. Based in New York,..

Enliven Therapeutics (ELVN) Stock Analysis: Biotech’s 168.67% Potential Upside Sparks Investor Interest

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is steadily capturing the attention of investors in the biotechnology sector with its innovative approach to cancer treatment. As a clinical-stage..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 47% Potential Upside for Healthcare Investors

HealthStream, Inc. (NASDAQ: HSTM) stands out in the healthcare sector, specializing in health information services with a robust focus on software applications designed to enhance healthcare..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Potential Upside of 35.84% Amid Strong Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS), a leader in the pediatric orthopedic medical device sector, presents a compelling opportunity for investors seeking exposure in the healthcare industry. With..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges in the Healthcare Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, specializes in medical device solutions that cater to a diverse market, including North America..

Oculis Holding AG (OCS) Stock Analysis: A Biotech with Over 124% Upside Potential

Oculis Holding AG (OCS), a Switzerland-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating ophthalmic diseases. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds